Begin main content

Daclatasvir

Last Updated: February 13, 2015
Result type: Reports
Project Number: SR0417-000
Product Line: Common Drug Review

Generic Name: Daclatasvir

Brand Name: Daklinza

Manufacturer: Bristol-Myers Squibb Canada Inc.

Indications: Hepatitis C, chronic

Submission Type: Pre-NOC

Project Status: Active

Date Recommendation Issued: September 21, 2015

Recommendation Type: List with clinical criteria and/or conditions

Tags

hepatitis c, hepatitis c, chronic, hepatitis